Cargando…
Biopharmaceuticals from microorganisms: from production to purification
The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156500/ https://www.ncbi.nlm.nih.gov/pubmed/27838289 http://dx.doi.org/10.1016/j.bjm.2016.10.007 |
_version_ | 1782481273612140544 |
---|---|
author | Jozala, Angela Faustino Geraldes, Danilo Costa Tundisi, Louise Lacalendola Feitosa, Valker de Araújo Breyer, Carlos Alexandre Cardoso, Samuel Leite Mazzola, Priscila Gava Oliveira-Nascimento, Laura de Rangel-Yagui, Carlota de Oliveira Magalhães, Pérola de Oliveira Oliveira, Marcos Antonio de Pessoa, Adalberto |
author_facet | Jozala, Angela Faustino Geraldes, Danilo Costa Tundisi, Louise Lacalendola Feitosa, Valker de Araújo Breyer, Carlos Alexandre Cardoso, Samuel Leite Mazzola, Priscila Gava Oliveira-Nascimento, Laura de Rangel-Yagui, Carlota de Oliveira Magalhães, Pérola de Oliveira Oliveira, Marcos Antonio de Pessoa, Adalberto |
author_sort | Jozala, Angela Faustino |
collection | PubMed |
description | The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques. In this review, we discuss the technology involved in the bioprocess and describe the available strategies and main advances in microbial fermentation and purification process to obtain biopharmaceuticals. |
format | Online Article Text |
id | pubmed-5156500 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-51565002016-12-19 Biopharmaceuticals from microorganisms: from production to purification Jozala, Angela Faustino Geraldes, Danilo Costa Tundisi, Louise Lacalendola Feitosa, Valker de Araújo Breyer, Carlos Alexandre Cardoso, Samuel Leite Mazzola, Priscila Gava Oliveira-Nascimento, Laura de Rangel-Yagui, Carlota de Oliveira Magalhães, Pérola de Oliveira Oliveira, Marcos Antonio de Pessoa, Adalberto Braz J Microbiol Review The use of biopharmaceuticals dates from the 19th century and within 5–10 years, up to 50% of all drugs in development will be biopharmaceuticals. In the 1980s, the biopharmaceutical industry experienced a significant growth in the production and approval of recombinant proteins such as interferons (IFN α, β, and γ) and growth hormones. The production of biopharmaceuticals, known as bioprocess, involves a wide range of techniques. In this review, we discuss the technology involved in the bioprocess and describe the available strategies and main advances in microbial fermentation and purification process to obtain biopharmaceuticals. Elsevier 2016-10-26 /pmc/articles/PMC5156500/ /pubmed/27838289 http://dx.doi.org/10.1016/j.bjm.2016.10.007 Text en © 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Jozala, Angela Faustino Geraldes, Danilo Costa Tundisi, Louise Lacalendola Feitosa, Valker de Araújo Breyer, Carlos Alexandre Cardoso, Samuel Leite Mazzola, Priscila Gava Oliveira-Nascimento, Laura de Rangel-Yagui, Carlota de Oliveira Magalhães, Pérola de Oliveira Oliveira, Marcos Antonio de Pessoa, Adalberto Biopharmaceuticals from microorganisms: from production to purification |
title | Biopharmaceuticals from microorganisms: from production to purification |
title_full | Biopharmaceuticals from microorganisms: from production to purification |
title_fullStr | Biopharmaceuticals from microorganisms: from production to purification |
title_full_unstemmed | Biopharmaceuticals from microorganisms: from production to purification |
title_short | Biopharmaceuticals from microorganisms: from production to purification |
title_sort | biopharmaceuticals from microorganisms: from production to purification |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156500/ https://www.ncbi.nlm.nih.gov/pubmed/27838289 http://dx.doi.org/10.1016/j.bjm.2016.10.007 |
work_keys_str_mv | AT jozalaangelafaustino biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT geraldesdanilocosta biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT tundisilouiselacalendola biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT feitosavalkerdearaujo biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT breyercarlosalexandre biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT cardososamuelleite biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT mazzolapriscilagava biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT oliveiranascimentolaurade biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT rangelyaguicarlotadeoliveira biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT magalhaesperoladeoliveira biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT oliveiramarcosantoniode biopharmaceuticalsfrommicroorganismsfromproductiontopurification AT pessoaadalberto biopharmaceuticalsfrommicroorganismsfromproductiontopurification |